Incidence, Timing, and Clinical Correlates of Streptococcus Mitis Bloodstream Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Ciprofloxacin Prophylaxis: A Single-Center Retrospective Study
Key Points
Bloodstream infections increased among hematopoietic cell transplant recipients receiving ciprofloxacin during their treatment.
Out of the cases, 20% occurred within the first month post-transplant, highlighting critical timing for infection risk.
Study employs a retrospective design, analyzing patient records from a single center to assess infection incidence and timing.
Findings indicate that prophylactic strategies may need adjustments to address the observed infection risk.
Incidence, Timing, and Clinical Correlates of Streptococcus Mitis Bloodstream Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Ciprofloxacin Prophylaxis: A Single-Center Retrospective Study | Synapse